TFF Pharmaceuticals (TFFP)
(Delayed Data from NSDQ)
$1.84 USD
-0.06 (-3.16%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $1.84 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TFFP 1.84 -0.06(-3.16%)
Will TFFP be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for TFFP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TFFP
TFF Pharmaceuticals (TFFP) Upgraded to Strong Buy: Here's Why
TFF Pharmaceuticals, Inc. (TFFP) Reports Q2 Loss, Tops Revenue Estimates
TFFP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Arcutis Biotherapeutics, Inc. (ARQT) Reports Q2 Loss, Misses Revenue Estimates
Praxis Precision Medicines, Inc. (PRAX) Reports Q2 Loss, Lags Revenue Estimates
Coherus BioSciences (CHRS) Reports Q2 Loss, Tops Revenue Estimates
Other News for TFFP
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
TFF Pharmaceuticals announces preclinical data published on TFF technology
TFF Pharmaceuticals? Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery